Radiation Therapy Onocology Group (RTOG)

RTOG 10305 Phase I/II trial of concurrent RAD001 (Everolimus) with Temozolomide/Radiation followed by adjuvant RAD001/Temozolomide in newly diagnosed glioblastoma (RTOG 0913)

RTOG 10025 A PHASE III STUDY OF POSTOPERATIVE RADIATION THERAPY (IMRT) +/- CETUXIMAB FOR LOCALLY-ADVANCED RESECTED HEAD AND NECK CANCER (RTOG 0920)

RTOG 07173 A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer

RTOG 07178 A Randomized Phase lll Comparison of Standard-Dose (60 Gy) Versus Highdose (74 Gy) Conformal Radiotherapy with Concurrent and  Consolidation Carboplatin/Paclitaxel in Patients with Stage IIIA/IIIB Non-SmallL Cell Lung Cancer

RTOG 08079 A Phase III Trial Of Short Term Androgen Deprivation With Pelvic Lymph Node Or Prostate Bed Only Radiotherapy (Spport) In Prostate Cancer Patients With A Rising Psa After Radical Prostatectomy.

RTOG 08183 A Phase III Trial Evaluating The Addition Of Cetuximab To Paclitaxel, Cisplatin, And Radiation For Patients With Esophageal Cancer Who Are Treated Without Surgery

RTOG 09200 A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy With or Without Short-Term Androgen Deprivation Therapy for Patients With Intermediate-Risk Prostate Cancer

Please contact the NYOH Research Department for more information on clinical trials at (518) 489-0044 ext. 1239